The phrase HiDAC (high dose cytarabine) is usually used to refer to the administration of high doses of cytarabine as a single agent (monotherapy) as part of consolidation treatment. This is where disease remission has already been achieved following induction therapy.

What is HiDAC for AML?

High-dose cytarabine (HiDAC) is an established component of most treatment regimens for adult AML and is incorporated into either the induction or consolidation phase of intensive chemotherapy. HiDAC-based consolidation therapy significantly improves the survival of adult patients with AML up to the age of 60 years.

What are the 4 main types of leukemia?

• Acute myeloid (or myelogenous) leukemia (AML)
• Chronic myeloid (or myelogenous) leukemia (CML)
• Acute lymphocytic (or lymphoblastic) leukemia (ALL)
• Chronic lymphocytic leukemia (CLL)